The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Erythromycin (NDC 70771-1549). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 70771-1548-1 in bottle of 100 tablets
Erythromycin Tablets USP, 250 mg
Rx only
100 tablets
250 mg Label (24a088e5 5eeb 4be9 8d6c 53067262e6c9 01)
NDC 70771-1549-1 in bottle of 100 tablets
Erythromycin Tablets USP, 500 mg
Rx only
100 tablets
500 mg Label (24a088e5 5eeb 4be9 8d6c 53067262e6c9 02)
* Please review the disclaimer below.
